33.03

0.12% 0.04

Omnicell Inc (OMCL)

Overview News Price History Option Chain Financials Discussions Forecast

Omnicell Inc stock is traded at $33.03, with a volume of 499.23K. It is up +0.12% in the last 24 hours and down -4.70% over the past month. Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Previous Close:

$32.99

Open:

$33.01

24h Volume:

499.23K

Relative Volume:

0.70

Market Cap:

$1.51B

Revenue:

$1.23B

Net Income/Loss:

$20.43M

P/E Ratio:

74.88

EPS:

0.4411

Net Cash Flow:

$95.39M

1W Performance:

+1.26%

1M Performance:

-4.70%

6M Performance:

-4.15%

1Y Performance:

+6.96%

1-Day Range:

$32.59

$33.23

1-Week Range:

$31.98

$33.58

52-Week Range:

$29.06

$55.00

Omnicell Inc Stock (OMCL) Company Profile

Name

Omnicell Inc

Sector

Healthcare (1068)

Industry

Health Information Services (47)

Phone

(877) 415-9990

Address

4220 NORTH FREEWAY, FORT WORTH

Employee

3,525

Twitter

@Omnicell

Next Earnings Date

2026-10-29

Latest SEC Filings

OMCL's Discussions on Twitter

Compare OMCL vs VEEV, TEM, BTSG, TXG, HNGE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OMCL Omnicell Inc	33.03	1.51B	1.23B	20.43M	95.39M	0.4411
VEEV Veeva Systems Inc	274.84	44.50B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	82.24	14.93B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	56.02	11.08B	13.65B	169.86M	412.12M	1.0758
TXG 10 X Genomics Inc	84.11	10.96B	638.78M	-22.66M	122.18M	-0.1744
HNGE Hinge Health Inc	91.98	7.42B	646.34M	-512.40M	202.76M	-6.6871

Omnicell Inc Stock (OMCL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-04-26	Upgrade	BofA Securities	Neutral → Buy
Jan-08-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
May-14-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-31-24	Downgrade	BofA Securities	Buy → Neutral
Aug-02-24	Upgrade	Barclays	Underweight → Equal Weight
Jan-03-24	Initiated	Barclays	Underweight
Nov-03-23	Downgrade	BTIG Research	Buy → Neutral
Nov-03-23	Upgrade	Piper Sandler	Neutral → Overweight
Nov-03-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-11-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Sep-26-23	Reiterated	Wells Fargo	Underweight
Aug-02-23	Downgrade	Piper Sandler	Overweight → Neutral
Jul-20-23	Downgrade	Wells Fargo	Overweight → Underweight
Feb-27-23	Upgrade	The Benchmark Company	Hold → Buy
Nov-03-22	Downgrade	The Benchmark Company	Buy → Hold
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight
Sep-09-22	Initiated	BofA Securities	Buy
Jul-15-22	Initiated	SVB Leerink	Mkt Perform
Dec-06-21	Resumed	Wells Fargo	Overweight
Jun-09-21	Initiated	JP Morgan	Neutral
May-24-21	Initiated	BTIG Research	Buy
Feb-02-21	Upgrade	Piper Sandler	Neutral → Overweight
Dec-08-20	Initiated	Berenberg	Buy
Dec-03-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-07-20	Initiated	Stephens	Overweight
Feb-07-20	Reiterated	Dougherty & Company	Buy
Nov-21-19	Reiterated	Dougherty & Company	Buy
Jul-26-19	Upgrade	Craig Hallum	Hold → Buy
Mar-07-19	Reiterated	Dougherty & Company	Buy
Jun-29-18	Resumed	The Benchmark Company	Buy
Sep-05-17	Reiterated	The Benchmark Company	Buy
Jul-28-17	Reiterated	Dougherty & Company	Buy
Apr-21-17	Downgrade	Piper Jaffray	Overweight → Neutral
Jan-19-17	Initiated	Dougherty & Company	Buy
Dec-06-16	Reiterated	The Benchmark Company	Buy
Jul-07-16	Reiterated	FBR Capital	Outperform
Mar-21-16	Reiterated	Topeka Capital Markets	Buy
Jan-07-16	Initiated	The Benchmark Company	Buy
Nov-16-15	Reiterated	Topeka Capital Markets	Buy
Oct-30-15	Reiterated	FBR Capital	Outperform
Sep-28-15	Upgrade	Sidoti	Neutral → Buy
Jul-31-15	Reiterated	Topeka Capital Markets	Buy

View All

Omnicell Inc Stock (OMCL) Latest News

Sep 24, 2026